drugset / Trial / NCT00542217
Phase Ia Dose-Escalation Safety, Pharmacodynamic and Pharmacokinetic Study of Imprime PGG™ Injection
RandomizedParallel-groupTriple-blind
Summary
The purpose of this trial is to the assess the safety, pharmacodynamics, and pharmacokinetics of escalating doses of Imprime PGG™ Injection in healthy volunteers.
Timeline
- Start
- 2005-12
- Primary completion
- —
- Completion
- 2006-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Imprime PGG | Other / unclassified | 0.5 mg/kg | Intravenous |
| Comparator | Imprime PGG | Other / unclassified | 1 mg/kg | Intravenous |
| Comparator | Imprime PGG | Other / unclassified | 2 mg/kg | Intravenous |
| Comparator | Imprime PGG | Other / unclassified | 4 mg/kg | Intravenous |
| Comparator | Imprime PGG | Other / unclassified | 6 mg/kg | Intravenous |
Indications
No indication recorded.